Anonymous ID: cf5a17 April 9, 2020, 10:22 a.m. No.8734679   🗄️.is 🔗kun

>>8734502

> I will bet all of you $2 trillion that when a vaccine finally comes to market it will be paying Anthony Fauci a royalty.

 

The same is true for his faggot friend Bill Haseltine

 

Those who control the federal funding and who have a vested interest in how COVID19 is dealt with going forward clearly prefer an immunologic as opposed to a small molecule therapeutic despite the fact that we have known about the primary role of ACE2 receptors in the lungs as the viral entry point for SARS coronaviruses since 2003 (Nature) and small molecule therapeutics like chloroquine since they were discovered by the CDC in 2005 (Virology Journal). But the big players such as Fauci and Haseltine conveniently ignored or minimized this research even going so far as calling it “anecdotal” despite the fact that the 2005 CDC paper has been cited more than 189 times in the ensuing 15 years. Because Fauci is on record in 2013, 2015, and 2017 predicting a reemergence of SARS CoV, he did nothing as the head of NIAID to facilitate pivotal clinical trials of hydroxychlorquine or other candidates required for FDA approval. Haseltine even went so far as to state there was "no market" for such small molecule therapeutics. "No market" in BIG PHARMA double speak means there is no way to turn cheap existing FDA approved drugs into the BILLION DOLLAR "Blockbuster" markets needed to sustain the medical elite establishment. Haseltine has a clear conflict of interest (COI), but FAILS to disclose it publicly in a national television interview (see below).

 

To make matters worse, his COI goes well beyond $$$, we are talking about the take over of the entire human race by means of instituting mandatory disease surveillance (nano implants) and immunologic treatment (vaccines and/or "hyper immune IgG") from cradle to grave as a Global Citizen under a one world global government (The China Model).

 

"Its sad to me that people are promoting [hydroxychlorquine]. We know already from studies that at best it will have a very mild effect…one study concludes that it has no effect. The net result is that if it has any effect, it will be very mild. The drug has been used for many years against many viruses to no effect…It is irresponsible to promote this drug at this time. I wish we had more hope. I tell you … the hopeful news is purified convalescent anti-serum that can really make a difference to people who are critically ill and eventually we will be able to protect health care workers as well. That I think is our nearest hope. That is convalescent anti-serum and the purification of that called "hyper immune IgG." Those are real possibilities to save lives and to protect our health care workers in the reasonably close future…" ~William A. Haseltine, 04/06/20, FOX Daily Brief with Dana Perine.

 

US Patent 2017/0096472 A1

 

ALBUMIN FUSION PROTENS

 

Applicant: Human Genome Sciences, Inc., Wilmington, DE (US)

 

Inventor: William A. Haseltine, New York, NY

 

Overly, Steven. "GlaxoSmithKline buys Human Genome Sciences for $3.6 Billion." Washington Post. July 16, 2012. Accessed 2012-07-16.